![Medical device makers rise on relief after Wegovy obesity trial data](/i/c/c2cf1c38-a638-b073-c1ae-c86b9f584560.webp)
Medical device makers rise on relief after Wegovy obesity trial data
Shares of U.S. medical device makers climbed in early trading on Monday as a potential hit from the
2023-11-13 23:45
![Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial](/i/c/252228df-9dfb-5e13-7107-56da386bdb76.webp)
Novo Shares Rise After Wegovy Demonstrates Heart Benefit in Trial
Novo Nordisk A/S gained another $14.5 billion of market value after a key study backed the use of
2023-11-13 20:53
![Wegovy's heart benefits due to more than weight loss, Novo says](/i/c/4540bb56-4ab7-a744-07ac-8173f5974c39.webp)
Wegovy's heart benefits due to more than weight loss, Novo says
By Patrick Wingrove PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity
2023-11-12 22:57
![Trump’s Bet in Iowa, Wegovy Study: Your Saturday US Briefing](/i/c/536b070b-d2de-27b2-a5d4-c3e1ce86e427.webp)
Trump’s Bet in Iowa, Wegovy Study: Your Saturday US Briefing
Good morning from Washington, where Congress is up against a Nov. 17 deadline when government funding runs out.Donald
2023-11-12 01:56
![Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease](/i/c/028b34ab-a51e-4fc1-4f5e-d4ba8dad29f8.webp)
Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss
2023-11-11 21:49
![Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits](/i/c/6671c1c1-ea6e-3746-5d05-2f50678ec438.webp)
Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits
The craze around pricey weight-loss drugs has many people clamoring for these treatments in company-sponsored health plans. While
2023-11-11 00:47
![Novo to Build $6 Billion Plant as Obesity Drug Demand Surges](/i/c/0ab5a5e3-f5c1-1286-e9e4-6e08689617c6.webp)
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
2023-11-10 21:25
![Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals](/i/c/0ae53384-e223-8466-4705-4cf8d95678dd.webp)
Drugmaker Novo Nordisk seeks obesity, diabetes 'bolt-on' deals
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN Novo Nordisk wants to buy more companies with drugs in early-
2023-11-10 19:20
![Weight-loss drug maker Novo Nordisk invests $6 billion to boost output](/i/c/25d00ef7-134e-f328-edb4-19841d7a4248.webp)
Weight-loss drug maker Novo Nordisk invests $6 billion to boost output
COPENHAGEN Novo Nordisk said on Friday it will invest more than 42 billion crowns ($6 billion) in its
2023-11-10 17:27
![Novavax posts higher-than-expected revenue, says prepared to further cut costs](/i/c/6ed19326-7263-fb3e-4c23-f065de44d248.webp)
Novavax posts higher-than-expected revenue, says prepared to further cut costs
(Reuters) -COVID-19 vaccine maker Novavax on Thursday reported higher-than-expected revenue for the third quarter, boosted by U.S. government grants to
2023-11-09 21:16
![Astra Enters Obesity Drug Race With Chinese Biotech Deal](/i/c/abc22a8e-b091-081c-a70a-374aa7d16daa.webp)
Astra Enters Obesity Drug Race With Chinese Biotech Deal
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines, agreeing
2023-11-09 18:54
![New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper](/i/c/19998c91-0156-05f8-9bef-4b4c8f5d77d5.webp)
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
An effective and massively popular weight-loss drug has made Novo Nordisk A/S billions of dollars and turned it
2023-11-09 07:22